baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

McCormick & Co Inc/ US5797802064 /

2024-05-10 9:59:59 PM	Chg. +0.79	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
76.14USD	+1.05%	22,153 Turnover: 1.68 mill.	-Bid Size: -	-Ask Size: -	20.44 bill.USD	2.05%	29.98

GlobeNewswire 05-09 Kronos Bio Reports First-Quarter 2024 Financial Results

GlobeNewswire 05-07 Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments

GlobeNewswire 05-02 BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

GlobeNewswire 05-02 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (s...

GlobeNewswire 05-02 BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to ...

GlobeNewswire 05-01 Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxi...

GlobeNewswire 04-30 Douglas Dynamics Reports First Quarter 2024 Results

GlobeNewswire 04-25 Y-mAbs to Present at 2024 ASCO Annual Meeting

GlobeNewswire 04-25 Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

GlobeNewswire 04-24 NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO...

GlobeNewswire 04-24 BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (AS...

GlobeNewswire 04-24 Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

GlobeNewswire 04-24 Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of ...

GlobeNewswire 04-24 Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...

GlobeNewswire 04-24 CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASC...

GlobeNewswire 04-24 Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B...

GlobeNewswire 04-24 BriaCell Announces Oral and Poster Presentations at ASCO 2024

GlobeNewswire 04-22 Loans Reach Another All-Time High, Credit Quality Remains Solid; TrustCo Reports Net Income of $12.1...

GlobeNewswire 04-16 Douglas Dynamics Announces First Quarter 2024 Earnings Release and Conference Call

GlobeNewswire 04-10 Sip with Me Cups now Available at Landry’s Rainforest Café

GlobeNewswire 03-27 Dyadic to Attend Industry Events in April

TeleTrader 03-26 US opens higher on data, Trump Media launch

GlobeNewswire 03-20 SERB Pharmaceuticals grants exclusive license to M8 Pharmaceuticals, an Acino company, to bring Vora...

GlobeNewswire 03-19 IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

McCormick & Co Inc/ US5797802064 /

If you wish to receive reply to your feedback, please provide your email address.